| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/14/2008 | WO2008018795A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018638A1 Fat absorption inhibitor and food and drink using the same |
| 02/14/2008 | WO2008018600A1 THERAPEUTIC AGENT FOR ACCELERATION OF SPINAL NERVE REPAIR COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 02/14/2008 | WO2008018597A1 Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | WO2008018448A1 Activator comprising biosurfactant as the active ingredient, mannosyl erythritol lipid and method of producing the same |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008018275A1 Anti-obesity agent and use thereof |
| 02/14/2008 | WO2008018190A1 Fat-derived neural crest cells |
| 02/14/2008 | WO2008017814A1 Prevention and treatment of microbial infection |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039940 Biological Tissue Sheet, Method Of Forming The Same And Transplantation Method By Using The Sheet |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039516 Composition of Solifenacin or Salt Thereof for Use in Solid Formulation |
| 02/14/2008 | US20080039511 Thiazole Compound and Use Thereof |
| 02/14/2008 | US20080039504 ethyl 5-(5-chloro-3-(4-chloro-3-(trifluoromethyl) phenylsulfonamido)pyridin-2-yl)-4-(isoxazol-3-yl)-4H-1,2,4-triazole-3-carboxylate; inflammation; chemokine receptor (CCR 9 or 2) antagonists |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039458 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039448 viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease; e.g. 1,1'[[(Propane-1,3-diyl)dioxy]bis(11aS)-11-sulpho-7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4-benzodiazepin-5-one]] sodium salt |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039420 Method for inhibiting NOX1 gene expression |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039414 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 02/14/2008 | US20080039412 Short interfering RNA sequences for use in therapeutic, veterinary, agricultural, diagnostic, target validation, and genomic discovery applications |
| 02/14/2008 | US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof |
| 02/14/2008 | US20080039366 Administering insulin, sodium citrate and phospholipid to respiratory tract |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038822 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/14/2008 | US20080038387 Therapy of estrogen-associated disorders |
| 02/14/2008 | US20080038361 Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands and Method of Preparation Thereof |
| 02/14/2008 | US20080038355 Bioadhesive dosage form of steroids |
| 02/14/2008 | US20080038320 Compositions and methods for enhancing vasodilation |
| 02/14/2008 | US20080038307 Biocompatible Coating, Method, and Use of Medical Surfaces |
| 02/14/2008 | US20080038296 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 02/14/2008 | US20080038290 Cosmetic slimming composition containing an extract of biomass of the alga neochloris oleoabundans |
| 02/14/2008 | US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen |
| 02/14/2008 | US20080038281 Model membrane systems |
| 02/14/2008 | US20080038274 Inhibition of secretion from non-neuronal cells |
| 02/14/2008 | US20080038270 Antibody Specific For A Chondroitin Sulphate Epitope |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038265 Antibodies to Erythropoietin Receptor and Uses Thereof |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038262 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 02/14/2008 | US20080038259 LFA-1 alpaha subunit antibodies and methods of use |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038253 Methods For Altering T Cell Diversity |
| 02/14/2008 | US20080038247 Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| 02/14/2008 | US20080038246 Crystallized Oxalate Decarboxylase And Methods Of Use |
| 02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
| 02/14/2008 | US20080038238 Human Stem Cell Materials and Methods |
| 02/14/2008 | US20080038232 Production of high mannose proteins in plant culture |
| 02/14/2008 | US20080038198 Method Of Screening Molecule Associated With Psychiatric Disorder |
| 02/14/2008 | US20080038196 Standardization of botanical products utilizing biological activity as a marker |
| 02/14/2008 | US20080038195 radiolabeling; neurodegenerative diseases |
| 02/14/2008 | US20080038194 System and Method for Expression Proteomics Based on Isotope Ratio Modification |
| 02/14/2008 | US20080035141 Aerosolized therapy kit |
| 02/14/2008 | DE202007016505U1 Re-Vital Kapseln für Männer Re-Vital Capsules for Men |
| 02/14/2008 | DE102007025045A1 Schlankmachende kosmetische Zusammensetzung mit einem Biomasseextrakt aus der Alge Neochloris oleoabundans Slimming cosmetic composition comprising an extract of the algae biomass Neochloris oleoabundans |
| 02/14/2008 | CA2660689A1 Spinal nerve repair promoting therapeutics containing des-acyl ghrelin or its derivatives as an active ingredient |
| 02/14/2008 | CA2660523A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 02/14/2008 | CA2660517A1 Spinal nerve repair promoting therapeutics containing ghrelin or its derivatives or substances that act on ghs-rla as an active ingredient |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | CA2659967A1 Quinazoline derivatives |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/14/2008 | CA2555617A1 Lee's golden dragon rub |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1887005A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1886993A1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 02/13/2008 | EP1886693A1 Agent for regeneration and/or protection of nerves |
| 02/13/2008 | EP1886691A2 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug |
| 02/13/2008 | EP1885725A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 02/13/2008 | EP1569665A4 Composition and method for mammary disinfection during winter conditions |
| 02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators |
| 02/13/2008 | EP1490025B1 Nanoparticulate compositions of map kinase inhibitors |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1476752A4 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1450814A4 Methods of inhibiting metastases |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1411923B1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1401816B1 Process for the production of the piperidine derivative fexofenadine |
| 02/13/2008 | EP1373234B1 Urokinase inhibitors |
| 02/13/2008 | EP1335908B1 Peroxisome proliferator activated receptor alpha agonists |